Journal for ImmunoTherapy of Cancer (Nov 2023)
1197 Site-specific anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy via enhancement of T cell penetration and engagement
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)